Analysts Lift JCI, Trim CoStar and HOOD

Analyst target prices shifted across a broad sweep of sectors on Wednesday, with building controls group JCI and healthcare operator HCA drawing the most positive revisions of the session.

Johnson Controls saw its average target price move to $172.45 from $169.70. The stock carries 12 hold ratings against just one buy among covering analysts. Consensus is nudging higher but remains cautious. HCA Healthcare pushed its consensus target to $470.59, up from $465.50, with two buys, nine holds and 16 sells on the board.

CoStar Group absorbed a target cut, with the consensus slipping to $36.65 from $37.42. That was one of the sharper moves downward on the day. Robinhood Markets also saw its target trimmed, falling to $132.90 from $134.90, despite the retail brokerage carrying a notably large analyst following of 32 names.

Xylem was a mixed picture. Its consensus target fell sharply to $132.75 from $142.63 after multiple simultaneous changes. One analyst cut their rating while others held.

Meta Platforms attracted a fresh target lift to $848.38, with 54 buy ratings underpinning the consensus, the largest coverage universe in today's batch.

Freeport-McMoRan edged lower on target to $78.70, reflecting copper market uncertainty. Royal Caribbean gained a small upgrade in target to $351.73, consistent with resilient cruise demand.